The success in marketing lagundi has equally benefited all farmers who grow and sell this shrub to manufacturers. An example of this are the lagundi farmers on the island of Palawan, in the southwest of the archipelago.
With the help of a non-governmental organization, the farmers have been able to secure a distribution agreement with Pascual to produce lagundi. Under that agreement, Pascual lent money to farmers to install solar-powered dryers and mills to produce powdered lagundi. Thanks to this new equipment, farmers have been able to produce more lagundi than before and improve their processing capacity.
- After two years, the farmers were not only able to repay Pascual’s loan, but also became important providers of lagundi, improving their living conditions and those of their families and communities.
- Palawan farmers have been able to benefit economically thanks to a distribution agreement with Pascual
Flag bearers of technology transfer and herbal medicines
The traditional knowledge related to lagundi, which has been passed down from generation to generation, has been transformed into a safe and scientifically validated herbal medicine. The help of the Government of the Philippines and the collaboration between pharmaceutical companies has enabled the transfer of technology and the clever use of IP structures such as utility models and trademarks has ensured its success.
Lagundi, previously used only by herbalists, today raises the living standards of local farmers and provides an affordable, safe and effective medicine for all.
On November 17, 2019, the first case of COVID-19 was identified in Wuhan, China, since then several health safety measures have been implemented to prevent the spread of this disease. However, the cases of contagion rose exponentially, given this, in March 2020 the World Health Organization (WHO) declared COVID-19 a pandemic.
Currently there are more than 55 million infections worldwide. The countries that lead the list of cases of infected people are the United States, India, Brazil, France and Russia.
In the last twelve months, while society lives under social distancing, scientists have been working hard, with the aim of developing a vaccine and anti-COVID-19 treatments. Despite this, the road has not been easy and the end of the pandemic is still uncertain.
Mexico and the pandemic
In Mexico, coronavirus cases are on the rise. By November 2020, the country exceeded one million people infected and totaled more than 100 thousand deaths, facing this scenario, the population must follow the health security measures proposed by the Secretary of Health.
According to research professor Iván Hernández Pacheco, deputy director of the Medical Service of the Autonomous University of the State of Hidalgo (UAEH), people must continue with prevention measures, since it is in their hands to reduce the spread of this disease.
“So far, continuous hand washing, the use of masks and a healthy distance are the measures that have proven effective in controlling the pandemic. We must remember that SARS-CoV-2 is a virus capable of being transmitted by air and by hands when we touch our eyes, nose and mouth”, detailed the researcher.
On the other hand, projects on the development of a vaccine against COVID-19 in Mexico are in the early stages, that is, clinical trials continue on animals.
From the perspective of Dr. Hernández Pacheco, this situation is due to the insufficient support of public and private resources in areas of innovation in Biomedical Sciences, since this is where universities can take the lead in developing this type of invocations, for which they require laboratories with a biosafety level 3 (BSL-3), which are very few in Mexico.